Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to a study led by researchers at the Stanford University School of Medicine. The findings were published online Sept. 17 in JAMA Network Open.
Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies – antibodies directed at their own tissues or at substances their immune cells secrete into the blood – than people without COVID-19, according to a new study.
In a series of short FAQ videos, Stanford Medicine pediatric infectious disease expert Yvonne Maldonado, MD, and two other pediatricians discuss the vaccines’ safety and efficacy, the need for everyone 12 years and older to be vaccinated and the status of ongoing clinical trials of COVID-19 vaccines for younger children. The videos are part of … Continued
In February, the National Institutes of Health terminated an ambitious clinical trial to study the effectiveness of COVID-19 convalescent plasma in treating patients with mild to moderate disease. The therapy, the NIH determined, showed little benefit in an interim analysis. In a new paper published on Aug. 18 in The New England Journal of Medicine, researchers … Continued
A long, randomized trial led by researchers at Stanford Medicine and Yale University has found that wearing a surgical face mask over the mouth and nose is an effective way to reduce the occurrence of COVID-19 in community settings. It also showed that relatively low-cost, targeted interventions to promote mask-wearing can significantly increase the use … Continued
CBS News-KPIX’s Anne Makovec interviews Dr. Jorge Salinas with Stanford Health Care about the latest on the Delta variant and the COVID-19 vaccines.
At Stanford, some physicians who have been treating COVID-19 patients and researching long COVID realized they needed a clinic specifically for patients like Flores. Stanford Health Care’s Post-Acute COVID-19 Syndrome Clinic, or PACS, opened in May. “As the pandemic, progressed, we started seeing patients with all kinds of lingering symptoms after their initial COVID infection, … Continued
The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine. The finding strongly supports the view that the second shot should not be skipped. The study, published July 12 in … Continued
A study by Stanford University School of Medicine investigators hints that people with COVID-19 may experience milder symptoms if certain cells of their immune systems “remember” previous encounters with seasonal coronaviruses—the ones that cause about a quarter of the common colds kids get.
Researchers at Stanford Medicine have discovered a possible link to the “brain fog” that some COVID-19 patients have experienced.